{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T13:40:25Z","timestamp":1739108425563,"version":"3.37.0"},"reference-count":3,"publisher":"American College of Physicians","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.7326\/acpj201902190-014","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T22:36:42Z","timestamp":1550529402000},"page":"JC14","source":"Crossref","is-referenced-by-count":0,"title":["Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults \u2265\u00a050 years"],"prefix":"10.7326","volume":"170","author":[{"given":"Henry S.","family":"Sacks","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York, USA (H.S.S.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ACPJ201902190-014-R2","unstructured":"Cunningham AL, Lal H, Kovac M, et al; ZOE-70 Study Group. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019-32. [PMID: 27626517]"},{"key":"ACPJ201902190-014-R3","doi-asserted-by":"crossref","unstructured":"Stadtmauer EA, Sullivan KM, Marty FM, et al. A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood. 2014;124:2921-9. [PMID: 25237196]","DOI":"10.1182\/blood-2014-04-573048"},{"key":"ACPJ201902190-014-R4","doi-asserted-by":"crossref","unstructured":"Berkowitz EM, Moyle G, Stellbrink HJ, et al; Zoster-015 HZ\/su Study Group. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study. J Infect Dis. 2015;211:1279-87. [PMID: 25371534]","DOI":"10.1093\/infdis\/jiu606"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ACPJ201902190-014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ACPJ201902190-014","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/annals.org\/aim\/fullarticle\/2725102\/review-adjuvant-recombinant-subunit-vaccine-prevents-herpes-zoster-more-than","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T13:01:33Z","timestamp":1739106093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ACPJ201902190-014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2,19]]}},"alternative-id":["10.7326\/ACPJ201902190-014"],"URL":"https:\/\/doi.org\/10.7326\/acpj201902190-014","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"type":"print","value":"0003-4819"},{"type":"electronic","value":"1539-3704"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}